北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 药剂科  > 期刊论文
学科主题: 临床医学
题名:
Efficacy and tolerability of canagliflozin as add-on to metformin in the treatment of type 2 diabetes mellitus: a meta-analysis
作者: Yang, Ting; Lu, Min; Ma, Lingyue; Zhou, Ying; Cui, Yimin
关键词: Canagliflozin ; Metformin ; Type 2 diabetes ; Meta-analysis
刊名: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
发表日期: 2015-11-01
DOI: 10.1007/s00228-015-1923-y
卷: 71, 期:11, 页:1325-1332
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Pharmacology & Pharmacy
研究领域[WOS]: Pharmacology & Pharmacy
关键词[WOS]: GLUCOSE COTRANSPORTER 2 ; BETA-CELL FUNCTION ; JAPANESE PATIENTS ; RANDOMIZED-TRIAL ; DOUBLE-BLIND ; GLYCEMIC CONTROL ; SAFETY ; INHIBITOR ; SULFONYLUREA ; SITAGLIPTIN
英文摘要:

The aim of this study is to assess the efficacy and tolerability of canagliflozin, a sodium-glucose cotransporter-2 (SGLT-2) inhibitor, added on to metformin in patients with type 2 diabetes mellitus (T2DM).

Literatures were searched from major electronic databases, as well as the Chinese State Food and Drug Administration and clinicaltrials.govfor unpublished studies. Only randomized controlled trials (RCTs) comparing canagliflozin with placebo in combination with metformin were included. Two reviewers independently selected studies, evaluated the risk of bias, and extracted data. The included RCTs were analyzed by the software RevMan 5.3 provided by the Cochrane Collaboration.

Six RCTs were chosen for the meta-analysis. Compared to placebo, canagliflozin produced absolute reduction in glycated hemoglobin A1c (HbA1c) (-0.66 % [-0.72 %, -0.61 %]). The proportion of patients who achieved target HbA1c was significantly greater in the canagliflozin-treated group (1.86 [1.69, 2.03]). Canagliflozin led to greater fasting plasma glucose (FPG) reduction of 1.49 mmol/L (100 mg/day) and 1.80 mmol/L (300 mg/day). Significant body weight loss of 2.09 % (100 mg/day) and 2.66 % (300 mg/day) with canagliflozin was observed. Canagliflozin was found to improve beta cell function in terms of homeostasis model assessment (HOMA2-%B) (15.59 % [12.84 %, 18.35 %]). Higher incidences of genital mycotic infection/female and pollakiuria (increased urine frequency) were noted with canagliflozin compared with placebo-controlled groups.

Canagliflozin is a potential option as an add-on to metformin based on its improvement in HbA1c, FPG, body weight, and beta cell function, but further studies are demanded to strengthen this evidence. Common adverse events (AEs) like genital mycotic infection/female and pollakiuria were identified.

语种: 英语
WOS记录号: WOS:000363262000004
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/53408
Appears in Collections:北京大学第一临床医学院_药剂科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: Peking Univ, Dept Pharm, Hosp 1, Beijing 100034, Peoples R China

Recommended Citation:
Yang, Ting,Lu, Min,Ma, Lingyue,et al. Efficacy and tolerability of canagliflozin as add-on to metformin in the treatment of type 2 diabetes mellitus: a meta-analysis[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,2015,71(11):1325-1332.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Yang, Ting]'s Articles
[Lu, Min]'s Articles
[Ma, Lingyue]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Yang, Ting]‘s Articles
[Lu, Min]‘s Articles
[Ma, Lingyue]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace